The invention relates to medical devices and methods for manufacturing such medical devices. In particular, the invention relates to introducers for catheters, methods for making such introducers, and methods for using such introducers. More particularly, the invention relates to self-sealing sheath introducers (both tear-away and non-tear-away), methods for manufacturing such introducers, and methods of using such introducers in medical procedures.
Tear-away sheath introducers (“sheath introducers” or “introducers”) and their use as medical devices are well known in the art. See, for example U.S. Pat. Nos. 6,814,718; 6,808,520; 6,808,509; 6,796,991; 6,740,101; 6,712,791; 6,712,789; 6,695,810; 6,641,564; 6,632,234; 6,623,460; 6,599,302; 6,361,559; and 5,558,652; as well as U.S. Patent Application Publication Nos. 2004/0260243, 2004/0254534, 2004/0176781, 2004/006330, 2004/097863, and 2002/072789, the disclosures of which are incorporated herein by reference. These introducers are used in medical procedures to insert a catheter into the body and provide vascular access to the vessel of a patient. The catheters are inserted via the introducers by first using a needle to create an access site. A dilator is then used to dilate the access site to allow a larger-diameter sheath introducer to be introduced into the vessel through the access site. The catheter is then inserted through the sheath introducer and into the vessel. After the catheter has been inserted, the sheath introducer is removed, leaving the catheter in the vessel.
As shown in
The tear-away hub 111 provides a means to contain the valve 113 while connecting the valve 113 and the sheath 130. The hub 111 typically has a “T” shape with the opposing ends of the “T” being grasped and pulled to split both the valve 113 and sheath 130. Thus, the hub 111 provides a mechanism to split the sheath 130 into two portions and allow the introducer to be split and removed from around the catheter. The hub 111 is also often manufactured of a rigid polymer.
The tear-away valve 113, however, is typically made of a flexible material (such as silicone) that provides a self-sealing slit. The valve 113 may be designed as one piece that tears in half during the splitting procedure, or as two (or more) pieces that separate from each other during the splitting procedure. With conventional introducers, the valve 113 is encapsulated by the hub 111.
The tear-away sheath 130 is normally manufactured as a thin-walled structure, often as an extrusion. The extrusion contains splitting means, i.e., score lines that facilitate splitting or a self-splitting propagating material (such as linearly-directional extrusion). The proximal end 132 of the sheath 130 is attached to the hub 111 using over-molding or any other known attachment mechanism. The distal end 134 of the sheath 130 can be tapered to provide a smooth transition at the dilator/sheath interface.
To use the introducer 100, it is inserted in the desired vessel. Then the dilator 140 is unlocked from the hub 111 and removed to allow room for a catheter (or any similar medical device) to be inserted into the sheath. The valve 113 remains stationary inside the hub 111 and blocks air and/or fluid from flowing through the sheath 130 and hub 111 when they are left behind after the dilator is removed. The valve 113 keeps the passage 105 clear until a catheter is inserted into the passage 105 through the valve.
The introducer 100 is typically used for larger catheters, i.e., those with a diameter of 12 to 16 French. These larger-diameter introducers are rigid due to their diameter and the material used to construct them. This rigidity allows the large catheters to overcome the frictional forces needed to push the catheter through the valve.
But inserting smaller catheters into smaller introducers is more difficult. Typical introducers designed for smaller catheters (i.e., those 3 to 12 French in diameter) are made with open communication between the access site and the vascular system once the dilator is removed. This open configuration exists because smaller catheters, due to their smaller diameter and material, are not rigid enough to overcome the frictional forces needed to push the catheter through the valve. In other words, it is like trying to “push” a rope through a hole: the rope (i.e., catheter) does not remain rigid enough for a user to push it through the hole (i.e., valve).
The open configuration between the vascular system and the environment, however, allows two serious clinical problems. First, air embolism into the vascular system which can result in patient injury and/or death. And second, release of potentially infectious bodily fluids (including blood) into the environment, resulting in exposure to the health care provider.
The invention relates to tear-away and non-tear-away sheath introducers for catheters, methods for making such introducers, and methods for using such introducers. The sheath introducers contain movable valves that are encapsulated in a movable housing that allows the valve to move along the axis of the introducer. As the movable valve and housing travel along the axis, a portion of the hub protrudes past the valve and is exposed. As well, the sheath introducers can also contain a stationary valve and housing that can be opened to expose a portion of the hub when a conduit penetrates the stationary valve. The conduit can include a one-way valve actuator that can penetrate and open the valve, yet remain attached to a portion of the introducer when the introducer is split for removal from a patient. In both instances, the protruding portion of the hub contains a friction-free pathway for a catheter into the sheath introducer. The introducers can therefore be used with any catheter, regardless of the size or material, because of the reduced or eliminated frictional force between the catheter and introducer.
The following description of the invention can be understood in light of
The following description provides specific details in order to provide a thorough understanding of the invention. The skilled artisan, however, would understand that the invention could be practiced without employing these specific details. Indeed, the invention can be practiced by modifying the illustrated method and resulting device and can be used in conjunction with apparatus and techniques conventionally used in the industry. For example, the invention is described as a micro-introducer for small catheters (3F-10F in size), but could easily be adapted for any size of catheter or device regardless of the size or intended use. Further, while the invention is described for use with catheters for vascular access, it could be used with any similar device that is used to grant a physician (or other user) access to a part of the body, whether human or animal.
The invention includes a tear-away or non-tear-away sheath introducer that contains a movable valve and housing that when moved, allows a portion of the hub to protrude through a valve and be exposed. The protruding portion of the hub contains a friction-free pathway for the catheter. Any inducer having these properties can be used in the invention, including the sheath introducer described below and illustrated in the Figures.
The sheath introducer of the invention contains several primary components. First, dilator means used to dilate the vascular system and create a pathway for the catheter. Second, means for sheathing the dilator means to protect it from the vascular system. And third, valve means for keeping the pathway created by the dilator closed until the catheter needs to be inserted.
One example of the sheath introducer is illustrated in
The valve housing 3 also contains any known means for positioning it with the sheath hub. An example of this positioning means is depicted in
The valve housing 3 can also contain any known interlock mechanism between the two halves of the valve housing. An example of this interlock mechanism is lock 19 that, when the halves are assembled together, serves to maintain uniform travel between both halves of the valve housing. This interlock mechanism can be supplemented with any known mechanism, including the detachable interlock features 17 and 18.
The sheath hub 7 contains several features for its operation. One such feature includes valve snap fit grooves and edges 21. These two components, along with the snap feature 13, work together to snap the valve housing 3 (and 6) to the sheath hub 7. Of course, any similar mechanism can be used to snap these two components to each other. The sheath hub 7 also contains the guide slot 22, as mentioned above, that guides the valve housing 3 (and 6) and the hub to the correct location relative to each other.
The sheath hub 7 also contains a valve penetration means. The valve penetration means operates to penetrate the two halves of the valve 4 and 5, thereby providing an opening in the valve. Any penetration means known in the art can be used for this function. As depicted in
The valve penetration means need not physically force (i.e., push) the valve halves 4 and 5 apart to penetrate the valve. In this aspect of the invention, the member 23 penetrates the valve halves 4 and 5 when the valve housings are pulled apart to expose the member 23. The valve housings can be pulled apart by the mechanisms described below.
When the penetration member 23 opens the valve in either of these manners, port 24 is exposed. The port 24 is the location where the catheter (or similar device) is inserted. Unlike the conventional introducers where the catheter is forced between the valve (which creates a friction force that must be overcome by a user), the catheter can be inserted in the port 24 of the introducers. The port 24 can be configured to have less friction than that required in conventional devices by providing an inside diameter slightly larger than that of the catheter insertion member. Alternatively, the port can be configured to have substantially no friction (“friction-free”) by providing an inside diameter significantly larger than that of the catheter insertion member. As well, the port 24 can be configured to have less or substantially no friction by providing a coating on the inside of the port 24 and/or the outside of the catheter.
The sheath hub 7 also contains activation means. The activation means is used to force the penetration member 23 up through the valve halves 4 and 5, move the valve halves (and housing) down over the member 23, or to pull the valve halves apart, to thereby open them and expose member 23 containing port 24. Any mechanism that operates in this manner can be use as the activation means. In the sheath hub depicted in
In some embodiments, the introducer can be configured so that the valve is stationary. In these embodiments, the stationary valve can be opened to expose a portion of a hub when conduit means penetrate the stationary valve. With a portion of the hub exposed, the catheter can then be inserted as described above.
One example of these embodiments is illustrated in
The valve 104 can be configured to be stationary within the assembled introducer 105 using any known mechanism. In the embodiments illustrated in
The valve housing 106 houses the stationary valve 104 and therefore the bottom of the housing 106 can be configured to substantially match the shape of the valve 104. As well, since the valve housing 106 is located on the sheath hub top 118, the bottom of the valve housing 106 can be configured to substantially match the upper surface of the sheath hub top 118. As depicted in
The valve housing 106 also surrounds the conduit means (i.e., conduit 110). Accordingly, the inner surface of the valve housing can be configured to substantially match the outer surface of the conduit 110. As depicted in
The conduit 110 moves along the axis of the assembled introducer 105 from a first position shown in
In other embodiments, the conduit 110 can move into an intermediate position anywhere between the first and second positions. The intermediate position can be selected so that the valve is opened by any desired amount. For example, the intermediate position for the conduit 110 can be selected so that a partially opened valve would allow only a small amount of blood to be exposed, ensuring that the introducer was located correctly in a vein.
The conduit means can have any configuration allowing it to operate in this manner. Thus, the outer surface of the conduit can be configured to be slightly smaller than the inner surface of the valve housing, allowing the conduit to move easily relative to the valve housing. If desired, additional mechanisms like depth control detents, springs, or coatings can be used to increase—or, if necessary, decrease—the ability of the outer surface of the conduit to move relative to the inner surface of the valve housing.
In some instances, the outer surface of the conduit 110 and the inner surface of the valve housing 106 can be configured so that the conduit can be retained in the first and second positions. Any retaining means known in the art can be used, such as markings, depth control detents, springs, threads or the retaining means illustrated in
The bottom 115 of the conduit 110 can be configured so that it pierces and opens the stationary valve 104. Thus, the bottom 115 of the conduit can be configured with any shape that will operate in this manner. In some instances, the bottom 115 is typically given a substantially pointed or substantially tapered shape. The bottom of the conduit can therefore initially open the valve and as the conduit moves further down, the opening in the valve becomes wider and wider allowing for a substantially friction-free passage way through the valve. In some instances, the bottom of the conduit can be rounded to prevent damage to the valve.
The top 127 of the conduit 110 can be configured with any shape so that it guides the placement of the catheter. One example of such a shape is depicted in
Once the assembled introducer 105 is located in the desired location, the user can open the valve easily by pressing on the top of the conduit means. This action forces the conduit 110 from the first position into the second position, and opens the valve. The user can then place the tip of a catheter in the top of the conduit. As the user pushes on the catheter, the tip is guided from the top of the conduit 110, though the inner chamber 120, past the opened valve, out the bottom of the conduit, and then into the sheath 108.
Reference is now made to
As shown in
A valve actuator 210 is also shown in
Reference is now made to
As mentioned, the conduit pathway 220 extends through the actuator 210 to enable a catheter to pass therethrough after the actuator has opened the valve 204. In the present embodiment, the surface of the conduit pathway 220 is conically shaped so as to guide the catheter in its passage through the actuator. As best seen in
The teeth 232 of the actuator 210 are configured to engage with corresponding interference features defined in the cavity 240 of the top cap 206, namely, teeth 242 defined on the inside surface of the cavity.
Grooves 244 are defined on the inside surface of the top cap cavity 240 to engage with the tongue 234 defined on the side of the actuator 210 when the actuator is received in the top cap cavity. Engagement of the actuator tongue 234 with one of the top cap cavity grooves 244 enables the actuator to slide longitudinally within the cavity 240, while causing the actuator to retain physical engagement with the respective half of the top cap 206 when the top cap, together with the rest of the introducer 205, is split apart in order to remove it from the vessel insertion site. In brief, the side surfaces of the teeth 242 adjacent the groove of the top cap cavity 240 are angled such that the actuator tongue 234 is captured in and retained by the groove, even when the top cap is split. This prevents the actuator 210 from falling out of the introducer 205 when split. Thus, the tongue 234 and/or grooves 244 operate as retaining members and therefore serve as one example of means for preventing separation of the valve actuator from a portion of the hub when hub is split. Note, however, that other means for providing this functionality may be included in the introducer. For instance, the valve actuator can be attached to a portion of the sheath hub by a living hinge, a tether, a magnetic feature, etc. These and other means for preventing such separation are therefore contemplated.
The top cap 206 includes tabs 246 that are configured to be received by corresponding grooves 248 (
Reference is made to
This provides a clear path via the actuator conduit pathway 220 for the catheter to pass through actuator, sheath hub 207, and sheath 108 for placement in the patient's vasculature. Later, when the catheter is placed, the introducer 205 can be split and removed from the vessel insertion site. Upon splitting, the tongue and groove engagement of the actuator 210 with the top cap cavity 240 enables the actuator to be retained with a corresponding split portion of the top cap 206. During the introducer splitting and removal, the already-placed catheter will pass through the actuator channel 230 to free the catheter from the actuator, as the actuator is non-splittable in the present embodiment.
In one embodiment, the composition of the sheath hub 207 includes a clear material, such as acrylic, e.g., polymethyl methacrylate, so as to enable the sheath hub to be translucent. This in turn enables a lower portion 240A of the cavity 240 (
The introducers described above can be modified and enhanced with several optional features. One of these modifications is a modified valve 30 as depicted in
The extensions 34 are designed to extend upwards from the valve 30 towards the dilator of the introducer. Like the base 32, the extensions 34 will abut the valve housing, but the sides rather than the bottom. Accordingly, the size and shape of the extensions 34 are selected to substantially match the inner surface of the valve housing which will enclose the valve 30. The extensions 34 contain a notch(es) 38 that correspond to the notches 50 provided in the protruding member 41 (as described below).
The channel portion 36 of the valve 30 also extends in an upward direction toward the dilator of the introducer. As shown in
The upper surface 42 of the channel portion contains a slit 40. The slit 40 does not extend the entire way across the channel portion 36 and so is a non-tear away slit. The slit 40 is held in a closed or sealed position (position A in
The channel portion 36 of the valve 30 can also operate as a sealing means around the protruding member 41. The sealing means helps provide a seal between the vascular system and the environment when the protruding member 41 has forced the slit 40 open. This sealing function is illustrated in
The advantage of valve 30 is that it can also serve as a flash-back chamber. If the valve 30 (and associated parts of the hub sheath) is made from a translucent or transparent material, it allows the user to view the inside of the valve 30. If sheath introducer 10 is placed in the proper location (i.e., in the venous system), blood will enter the valve chamber resulting in a red color as an indication that the sheath introducer is placed correctly. Using a translucent or transparent material for the valve 30 therefore allows the user to look through the valve and determine whether this red color is showing.
As mentioned above, a seal can be formed between the channel portion 36 and the protruding member 41. To help improve the seal between these two components, the protruding member 41 can be modified by providing stress risers (45 and 46) on the inside 40 and the outside 41 of the protruding member 41 as shown in
The stress riser 45 begins on the bottom of the sheath hub 47 and continues along the outside of the sheath hub until the stress riser 45 reaches a point below the initial location of the valve ring sealing member 39. At that point, the stress riser 46 moves to the inside of the protruding member 41 and then continues to the notch 50. The depth and width of the stress risers 45 and 46 are selected depending on the required separation force.
Another function of the stress risers 45 and 46 are to act as an initiator in the splitting process. By their nature, the stress risers are the beginning of a split in the hub sheath 47 and, therefore, can be used to make the splitting process easier. Accordingly, the stress risers 45 and 46 are located substantially on the axis where the introducer 10 will be split.
Another optional modification that can be made to the sheath introducer comprises notches 50 in the upper portion of the protruding member 41 that remain above the valve 30 in the extended position. The notches 50 give the protruding member 41 additional length to extend past the valve 30 while at the same time not adding additional length to the stress risers 45 and 46. Such a configuration adds length to the protruding member 41 without increasing the cracking force needed to split the introducer 10.
As shown in
The sheath hub 47 can also be optionally modified to increase the attachment between the sheath hub 47 and the sheath 53. One manner to increase this attachment is depicted in
In some embodiments, the sheath cap 57 can affixed to the sheath hub 47 by means of a thermal, solvent or UV bond. In other embodiments, the sheath cap 57 can be affixed to the sheath hub 47 using a mechanical connection as known in the art, including a friction fit, snap fit, or ultrasonic weld. One example of such a mechanical connection is illustrated in
Another method to increase the attachment sheath hub 47 and the sheath 53 is illustrated in
A similar, but different, configuration is depicted in
Alternatively, another method to increase this attachment is depicted in
In yet another modification, the sheath introducer can be provided with means for separating the valve housing 33 away from the sheath hub 47. Any known means for forcing these two components apart can be used in the invention, including leaf spring, coil spring, hinge, and/or a mechanical lever. As depicted in
One result of the separation of these two components is the movement of valve 30 relative to the protruding member 41. When these two components are attached to each other, the spring is compressed and the valve 30 slides down the protruding member which then opens the slit 40 of the valve 30. When these components are separated, the pressure of the spring 65 is released and it returns to the uncompressed state, sliding the valve 30 back up the protruding member and closing the slit 40.
In another modification, the valve housing of the introducer could be engaged by means of a rotary movement along the axis of a threaded member or any other mechanical means to translate the valve housing along the desired path. For example, a mechanical lever, push button, or threaded member could be used in this modification.
In addition to any previously indicated variation, numerous other modifications and alternative arrangements may be devised by those skilled in the art without departing from the spirit and scope of the invention and appended claims are intended to cover such modifications and arrangements. Thus, while the invention has been described above with particularity and detail in connection with what is presently deemed to be the most practical and preferred aspects of the invention, it will be apparent to those of ordinary skill in the art that numerous modifications, including but not limited to, form, function, manner of operations and use may be made without departing form the principles and concepts set forth herein.
This application is a continuation of U.S. patent application Ser. No. 13/849,261, filed Mar. 22, 2013, now U.S. Pat. No. 9,101,737, which is a continuation of U.S. patent application Ser. No. 12/399,749, filed Mar. 6, 2009, now U.S. Pat. No. 8,403,890, which is a continuation-in-part of U.S. patent application Ser. No. 11/531,339, filed Sep. 13, 2006, now U.S. Pat. No. 8,932,260, which is a continuation-in-part of U.S. patent application Ser. No. 11/288,959, filed Nov. 29, 2005, which claims the benefit of priority to U.S. Provisional Patent Application No. 60/631,397, filed Nov. 29, 2004, each of which applications is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
675157 | Howard | May 1901 | A |
2908283 | Kiffer et al. | Oct 1959 | A |
2912981 | Keough | Nov 1959 | A |
3176690 | H'Doubler | Apr 1965 | A |
D217795 | Spaven | Jun 1970 | S |
3612050 | Sheridan | Oct 1971 | A |
3805794 | Schlesinger | Apr 1974 | A |
3853127 | Spademan | Dec 1974 | A |
4000739 | Stevens | Jan 1977 | A |
4068659 | Moorehead | Jan 1978 | A |
4089506 | Blake | May 1978 | A |
4143853 | Abramson | Mar 1979 | A |
4198973 | Millet | Apr 1980 | A |
4233974 | Desecki et al. | Nov 1980 | A |
4296747 | Ogle | Oct 1981 | A |
4306562 | Osborne | Dec 1981 | A |
4354491 | Marbry | Oct 1982 | A |
4387879 | Tauschinski | Jun 1983 | A |
4411654 | Boarini et al. | Oct 1983 | A |
4412832 | Kling et al. | Nov 1983 | A |
4424833 | Spector et al. | Jan 1984 | A |
4430081 | Timmermans | Feb 1984 | A |
4431426 | Groshong et al. | Feb 1984 | A |
4436519 | O'Neill | Mar 1984 | A |
4445893 | Bodicky | May 1984 | A |
4449973 | Luther | May 1984 | A |
4453928 | Steiger | Jun 1984 | A |
4468224 | Enzmann et al. | Aug 1984 | A |
4473067 | Schiff | Sep 1984 | A |
RE31855 | Osborne | Mar 1985 | E |
4504269 | Durand et al. | Mar 1985 | A |
4557261 | Rugheimer et al. | Dec 1985 | A |
4571241 | Christopher | Feb 1986 | A |
4581012 | Brown et al. | Apr 1986 | A |
4581025 | Timmermans | Apr 1986 | A |
4588398 | Daugherty et al. | May 1986 | A |
4591355 | Hilse | May 1986 | A |
4596559 | Fleischhacker | Jun 1986 | A |
4610665 | Matsumoto et al. | Sep 1986 | A |
4610671 | Luther | Sep 1986 | A |
4619643 | Bai | Oct 1986 | A |
4626245 | Weinstein | Dec 1986 | A |
4634432 | Kocak | Jan 1987 | A |
4650472 | Bates | Mar 1987 | A |
4654031 | Lentz | Mar 1987 | A |
4657772 | Kocak | Apr 1987 | A |
4673393 | Suzuki et al. | Jun 1987 | A |
4701159 | Brown et al. | Oct 1987 | A |
4705511 | Kocak | Nov 1987 | A |
4722725 | Sawyer et al. | Feb 1988 | A |
4723550 | Bales et al. | Feb 1988 | A |
4726374 | Bales et al. | Feb 1988 | A |
4743265 | Whitehouse et al. | May 1988 | A |
4747833 | Kousai et al. | May 1988 | A |
4748982 | Horzewski et al. | Jun 1988 | A |
4753765 | Pande | Jun 1988 | A |
4772266 | Groshong | Sep 1988 | A |
4784644 | Sawyer et al. | Nov 1988 | A |
4795426 | Jones | Jan 1989 | A |
4798594 | Hillstead | Jan 1989 | A |
4809679 | Shimonaka et al. | Mar 1989 | A |
4842591 | Luther | Jun 1989 | A |
4842592 | Caggiani et al. | Jun 1989 | A |
4865593 | Ogawa et al. | Sep 1989 | A |
4895565 | Hillstead | Jan 1990 | A |
4909798 | Fleischhacker et al. | Mar 1990 | A |
4921479 | Grayzel | May 1990 | A |
4929235 | Merry et al. | May 1990 | A |
4929236 | Sampson | May 1990 | A |
4932633 | Johnson et al. | Jun 1990 | A |
4935010 | Cox et al. | Jun 1990 | A |
4936826 | Amarasinghe | Jun 1990 | A |
4946133 | Johnson et al. | Aug 1990 | A |
4952359 | Wells | Aug 1990 | A |
4956755 | Maglica et al. | Sep 1990 | A |
4960412 | Fink | Oct 1990 | A |
4966588 | Rayman et al. | Oct 1990 | A |
4973312 | Andrew | Nov 1990 | A |
4983168 | Moorehead | Jan 1991 | A |
4994027 | Farrell | Feb 1991 | A |
4997424 | Little | Mar 1991 | A |
5000745 | Guest et al. | Mar 1991 | A |
5007901 | Shields | Apr 1991 | A |
5009391 | Steigerwald | Apr 1991 | A |
5011478 | Cope | Apr 1991 | A |
5035686 | Crittenden et al. | Jul 1991 | A |
5041095 | Littrell | Aug 1991 | A |
5053014 | Van Heugten | Oct 1991 | A |
5064414 | Revane | Nov 1991 | A |
5066285 | Hillstead | Nov 1991 | A |
5071411 | Hillstead | Dec 1991 | A |
5078688 | Lobodzinski et al. | Jan 1992 | A |
5085645 | Purdy et al. | Feb 1992 | A |
5092857 | Fleischhacker | Mar 1992 | A |
5098392 | Fleischhacker et al. | Mar 1992 | A |
5098393 | Amplatz et al. | Mar 1992 | A |
5102395 | Cheer et al. | Apr 1992 | A |
5104389 | Deem et al. | Apr 1992 | A |
5106054 | Mollenauer et al. | Apr 1992 | A |
5112301 | Fenton, Jr. et al. | May 1992 | A |
5114408 | Fleischhaker et al. | May 1992 | A |
5117836 | Millar | Jun 1992 | A |
5125903 | McLaughlin et al. | Jun 1992 | A |
5125904 | Lee | Jun 1992 | A |
5141497 | Erskine | Aug 1992 | A |
5149327 | Oshiyama | Sep 1992 | A |
5154701 | Cheer et al. | Oct 1992 | A |
5156596 | Balbierz et al. | Oct 1992 | A |
5158545 | Trudell et al. | Oct 1992 | A |
5160323 | Andrew et al. | Nov 1992 | A |
5163903 | Crittenden et al. | Nov 1992 | A |
5167634 | Corrigan, Jr. et al. | Dec 1992 | A |
5167637 | Okada et al. | Dec 1992 | A |
5169393 | Moorehead et al. | Dec 1992 | A |
5171222 | Euteneuer et al. | Dec 1992 | A |
5176652 | Littrell | Jan 1993 | A |
5180372 | Vegoe et al. | Jan 1993 | A |
5188605 | Sleep | Feb 1993 | A |
5190529 | McCrory et al. | Mar 1993 | A |
5191898 | Millar | Mar 1993 | A |
5197976 | Herweck et al. | Mar 1993 | A |
5201722 | Moorehead et al. | Apr 1993 | A |
5205834 | Moorehead et al. | Apr 1993 | A |
5207649 | Aruny | May 1993 | A |
5211633 | Stouder, Jr. | May 1993 | A |
5215538 | Larkin | Jun 1993 | A |
5221263 | Sinko et al. | Jun 1993 | A |
5224930 | Spaeth et al. | Jul 1993 | A |
5234407 | Teirstein et al. | Aug 1993 | A |
5234410 | Graham et al. | Aug 1993 | A |
5234438 | Semrad | Aug 1993 | A |
5242413 | Heiliger | Sep 1993 | A |
5242430 | Arenas et al. | Sep 1993 | A |
5242431 | Kristiansen | Sep 1993 | A |
5250033 | Evans et al. | Oct 1993 | A |
5255691 | Otten | Oct 1993 | A |
5269771 | Thomas et al. | Dec 1993 | A |
5273540 | Luther et al. | Dec 1993 | A |
5273546 | McLaughlin et al. | Dec 1993 | A |
5275583 | Crainich | Jan 1994 | A |
5279597 | Dassa et al. | Jan 1994 | A |
5290294 | Cox et al. | Mar 1994 | A |
5292311 | Cope | Mar 1994 | A |
5304142 | Liebl et al. | Apr 1994 | A |
5304156 | Sylvanowicz et al. | Apr 1994 | A |
5306240 | Berry | Apr 1994 | A |
5312355 | Lee | May 1994 | A |
5312357 | Buijs et al. | May 1994 | A |
5318542 | Hirsch et al. | Jun 1994 | A |
5320602 | Karpiel | Jun 1994 | A |
5324271 | Abiuso et al. | Jun 1994 | A |
5334157 | Klein et al. | Aug 1994 | A |
5334187 | Fischell et al. | Aug 1994 | A |
5336192 | Palestrant | Aug 1994 | A |
5348537 | Wiesner et al. | Sep 1994 | A |
5350362 | Stouder, Jr. | Sep 1994 | A |
5350363 | Goode et al. | Sep 1994 | A |
5364393 | Auth et al. | Nov 1994 | A |
5368574 | Antonacci et al. | Nov 1994 | A |
5382241 | Choudhury et al. | Jan 1995 | A |
5389081 | Castro | Feb 1995 | A |
5389090 | Fischell et al. | Feb 1995 | A |
5391152 | Patterson | Feb 1995 | A |
5395352 | Penny | Mar 1995 | A |
5397310 | Chu et al. | Mar 1995 | A |
5397311 | Walker et al. | Mar 1995 | A |
5405320 | Twardowski et al. | Apr 1995 | A |
5405323 | Rogers et al. | Apr 1995 | A |
5405329 | Durand | Apr 1995 | A |
5409463 | Thomas et al. | Apr 1995 | A |
5409464 | Villalobos | Apr 1995 | A |
5409469 | Schaerf | Apr 1995 | A |
5413561 | Fischell et al. | May 1995 | A |
5419340 | Stevens | May 1995 | A |
5423762 | Hillstead | Jun 1995 | A |
5429616 | Schaffer | Jul 1995 | A |
5437645 | Urban et al. | Aug 1995 | A |
5441504 | Pohndorf et al. | Aug 1995 | A |
5453095 | Davila et al. | Sep 1995 | A |
5460616 | Weinstein et al. | Oct 1995 | A |
5466230 | Davila | Nov 1995 | A |
5472418 | Palestrant | Dec 1995 | A |
5472435 | Sutton | Dec 1995 | A |
5474099 | Boehmer et al. | Dec 1995 | A |
5474544 | Lynn | Dec 1995 | A |
5484401 | Rodriguez et al. | Jan 1996 | A |
5488960 | Toner | Feb 1996 | A |
5489269 | Aldrich et al. | Feb 1996 | A |
5489273 | Whitney et al. | Feb 1996 | A |
5496346 | Horzewski et al. | Mar 1996 | A |
5499975 | Cope et al. | Mar 1996 | A |
5501676 | Niedospial et al. | Mar 1996 | A |
5509897 | Twardowski et al. | Apr 1996 | A |
5520655 | Davila et al. | May 1996 | A |
5536255 | Moss | Jul 1996 | A |
5538505 | Weinstein et al. | Jul 1996 | A |
5549651 | Lynn | Aug 1996 | A |
5556387 | Mollenauer et al. | Sep 1996 | A |
5558652 | Henke | Sep 1996 | A |
5599305 | Hermann et al. | Feb 1997 | A |
5603702 | Smith et al. | Feb 1997 | A |
5613663 | Schmidt et al. | Mar 1997 | A |
5613953 | Pohndorf | Mar 1997 | A |
5613956 | Patterson et al. | Mar 1997 | A |
5647857 | Anderson et al. | Jul 1997 | A |
5653697 | Quiachon et al. | Aug 1997 | A |
5653698 | Niedospial et al. | Aug 1997 | A |
5657963 | Hinchliffe et al. | Aug 1997 | A |
5662606 | Cimino et al. | Sep 1997 | A |
5672158 | Okada et al. | Sep 1997 | A |
5685856 | Lehrer | Nov 1997 | A |
5685858 | Kawand | Nov 1997 | A |
5702370 | Sylvanowicz et al. | Dec 1997 | A |
5713867 | Morris | Feb 1998 | A |
5727770 | Dennis | Mar 1998 | A |
5735819 | Elliott | Apr 1998 | A |
5741233 | Riddle et al. | Apr 1998 | A |
5741234 | Aboul-Hosn | Apr 1998 | A |
5752937 | Otten et al. | May 1998 | A |
5755693 | Walker et al. | May 1998 | A |
5755702 | Hillstead et al. | May 1998 | A |
5766203 | Imran et al. | Jun 1998 | A |
5772678 | Thomason et al. | Jun 1998 | A |
5782807 | Falvai et al. | Jul 1998 | A |
5782812 | Hart et al. | Jul 1998 | A |
5782817 | Franzel et al. | Jul 1998 | A |
5800414 | Cazal | Sep 1998 | A |
5807350 | Diaz | Sep 1998 | A |
5817069 | Arnett | Oct 1998 | A |
5843031 | Hermann et al. | Dec 1998 | A |
5853393 | Bogert | Dec 1998 | A |
5858007 | Fagan et al. | Jan 1999 | A |
5879333 | Smith et al. | Mar 1999 | A |
5885217 | Gisselberg et al. | Mar 1999 | A |
5895376 | Schwartz et al. | Apr 1999 | A |
5911710 | Barry et al. | Jun 1999 | A |
5916194 | Jacobsen et al. | Jun 1999 | A |
5919160 | Sanfilippo, II | Jul 1999 | A |
5921968 | Lampropoulos et al. | Jul 1999 | A |
5935112 | Stevens et al. | Aug 1999 | A |
5935122 | Fourkas et al. | Aug 1999 | A |
5944695 | Johnson et al. | Aug 1999 | A |
5951518 | Licata et al. | Sep 1999 | A |
5957912 | Heitzmann | Sep 1999 | A |
5967490 | Pike | Oct 1999 | A |
5971958 | Zhang | Oct 1999 | A |
5997562 | Zadno-Azizi et al. | Dec 1999 | A |
6017352 | Nash et al. | Jan 2000 | A |
6024729 | Dehdashtian et al. | Feb 2000 | A |
6027480 | Davis et al. | Feb 2000 | A |
6033375 | Brumbach | Mar 2000 | A |
6033388 | Nordstrom et al. | Mar 2000 | A |
6053904 | Scribner et al. | Apr 2000 | A |
6074377 | Sanfilippo, II | Jun 2000 | A |
6080141 | Castro et al. | Jun 2000 | A |
6083207 | Heck | Jul 2000 | A |
6086570 | Aboul-Hosn et al. | Jul 2000 | A |
6088889 | Luther et al. | Jul 2000 | A |
6106540 | White et al. | Aug 2000 | A |
6120476 | Fung et al. | Sep 2000 | A |
6120480 | Zhang et al. | Sep 2000 | A |
6120494 | Jonkman | Sep 2000 | A |
6142981 | Heck et al. | Nov 2000 | A |
6156054 | Zadno-Azizi et al. | Dec 2000 | A |
6159198 | Gardeski et al. | Dec 2000 | A |
6162196 | Hart et al. | Dec 2000 | A |
6171281 | Zhang | Jan 2001 | B1 |
6210366 | Sanfilippo, II | Apr 2001 | B1 |
6213988 | McIvor et al. | Apr 2001 | B1 |
6221057 | Schwartz et al. | Apr 2001 | B1 |
6228062 | Howell et al. | May 2001 | B1 |
6251119 | Addis | Jun 2001 | B1 |
6258058 | Sanfilippo, II | Jul 2001 | B1 |
6273871 | Davis et al. | Aug 2001 | B1 |
6276661 | Laird | Aug 2001 | B1 |
6277108 | McBroom et al. | Aug 2001 | B1 |
6287280 | Lampropoulos et al. | Sep 2001 | B1 |
D450839 | Junker | Nov 2001 | S |
6322541 | West et al. | Nov 2001 | B2 |
6331176 | Becker et al. | Dec 2001 | B1 |
6338725 | Hermann et al. | Jan 2002 | B1 |
6352520 | Miyazaki et al. | Mar 2002 | B1 |
6358460 | Hunt, Jr. et al. | Mar 2002 | B1 |
6361559 | Houser et al. | Mar 2002 | B1 |
6375157 | Van de Lande | Apr 2002 | B1 |
6402723 | Lampropoulos et al. | Jun 2002 | B1 |
6413250 | Smith et al. | Jul 2002 | B1 |
6416499 | Paul, Jr. | Jul 2002 | B2 |
6454744 | Spohn et al. | Sep 2002 | B1 |
6458103 | Albert et al. | Oct 2002 | B1 |
6494860 | Rocamora et al. | Dec 2002 | B2 |
6497681 | Brenner | Dec 2002 | B1 |
6508790 | Lawrence | Jan 2003 | B1 |
6520939 | Lafontaine | Feb 2003 | B2 |
6544247 | Gardeski et al. | Apr 2003 | B1 |
6551283 | Guo et al. | Apr 2003 | B1 |
6575960 | Becker et al. | Jun 2003 | B2 |
6589214 | McGuckin, Jr. et al. | Jul 2003 | B2 |
6589262 | Honebrink et al. | Jul 2003 | B1 |
6592544 | Mooney et al. | Jul 2003 | B1 |
6592553 | Zhang et al. | Jul 2003 | B2 |
6595959 | Stratienko | Jul 2003 | B1 |
6599302 | Houser et al. | Jul 2003 | B2 |
6623460 | Heck | Sep 2003 | B1 |
6632200 | Guo et al. | Oct 2003 | B2 |
6632234 | Kieturakis et al. | Oct 2003 | B2 |
6638242 | Wilson et al. | Oct 2003 | B2 |
6641564 | Kraus | Nov 2003 | B1 |
6645178 | Junker et al. | Nov 2003 | B1 |
6652492 | Bell et al. | Nov 2003 | B1 |
6655660 | Wales | Dec 2003 | B2 |
6663595 | Spohn et al. | Dec 2003 | B2 |
6666853 | Chu et al. | Dec 2003 | B2 |
6682498 | Ross | Jan 2004 | B2 |
6682519 | Schon | Jan 2004 | B1 |
6692464 | Graf | Feb 2004 | B2 |
6695810 | Peacock, III et al. | Feb 2004 | B2 |
6695832 | Schon et al. | Feb 2004 | B2 |
6712789 | Lange et al. | Mar 2004 | B1 |
6712791 | Lui et al. | Mar 2004 | B2 |
6719749 | Schweikert et al. | Apr 2004 | B1 |
6740101 | Houser et al. | May 2004 | B2 |
6776774 | Tansey, Jr. et al. | Aug 2004 | B2 |
6796991 | Nardeo | Sep 2004 | B2 |
6808502 | Nguyen | Oct 2004 | B2 |
6808509 | Davey | Oct 2004 | B1 |
6808520 | Fourkas et al. | Oct 2004 | B1 |
6814718 | McGuckin, Jr. et al. | Nov 2004 | B2 |
6827709 | Fujii | Dec 2004 | B2 |
6827710 | Mooney et al. | Dec 2004 | B1 |
6872198 | Wilson et al. | Mar 2005 | B1 |
6881211 | Schweikert et al. | Apr 2005 | B2 |
6887220 | Hogendijk | May 2005 | B2 |
6887417 | Gawreluk et al. | May 2005 | B1 |
6913594 | Coleman et al. | Jul 2005 | B2 |
6916313 | Cunningham | Jul 2005 | B2 |
6966886 | Appling | Nov 2005 | B2 |
7001396 | Glazier et al. | Feb 2006 | B2 |
7017886 | Ngene-Igwe | Mar 2006 | B1 |
7100690 | Mullen et al. | Sep 2006 | B2 |
7100890 | Cote, Sr. et al. | Sep 2006 | B2 |
7101353 | Lui et al. | Sep 2006 | B2 |
7166088 | Heuser | Jan 2007 | B2 |
7192433 | Osypka et al. | Mar 2007 | B2 |
7294296 | Davey | Nov 2007 | B2 |
7524305 | Moyer | Apr 2009 | B2 |
7637893 | Christensen et al. | Dec 2009 | B2 |
8105315 | Johnson et al. | Jan 2012 | B2 |
8403890 | King et al. | Mar 2013 | B2 |
8720065 | Christensen et al. | May 2014 | B2 |
8926564 | King et al. | Jan 2015 | B2 |
8932260 | King et al. | Jan 2015 | B2 |
20010001813 | West et al. | May 2001 | A1 |
20010041872 | Paul | Nov 2001 | A1 |
20010041873 | Dopper et al. | Nov 2001 | A1 |
20010041875 | Higuchi et al. | Nov 2001 | A1 |
20010049499 | Lui et al. | Dec 2001 | A1 |
20020010425 | Guo et al. | Jan 2002 | A1 |
20020038106 | Fujii | Mar 2002 | A1 |
20020042789 | Michalewicz et al. | Apr 2002 | A1 |
20020055715 | Young et al. | May 2002 | A1 |
20020068898 | McGuckin et al. | Jun 2002 | A1 |
20020068899 | McGuckin et al. | Jun 2002 | A1 |
20020072789 | Hackett et al. | Jun 2002 | A1 |
20020107482 | Rocamora et al. | Aug 2002 | A1 |
20020128604 | Nakajima | Sep 2002 | A1 |
20030014015 | Tansey et al. | Jan 2003 | A1 |
20030050604 | Lui et al. | Mar 2003 | A1 |
20030163139 | Graf | Aug 2003 | A1 |
20030216771 | Osypka et al. | Nov 2003 | A1 |
20040006330 | Fangrow | Jan 2004 | A1 |
20040030319 | Korkor et al. | Feb 2004 | A1 |
20040049499 | Nomoto et al. | Mar 2004 | A1 |
20040059296 | Godfrey | Mar 2004 | A1 |
20040065333 | Wilson et al. | Apr 2004 | A1 |
20040082913 | Spohn et al. | Apr 2004 | A1 |
20040092863 | Raulerson et al. | May 2004 | A1 |
20040092879 | Kraus et al. | May 2004 | A1 |
20040097863 | Appling | May 2004 | A1 |
20040097903 | Raulerson | May 2004 | A1 |
20040103229 | Callum | May 2004 | A1 |
20040122418 | Voorhees | Jun 2004 | A1 |
20040158208 | Hiejima | Aug 2004 | A1 |
20040167478 | Mooney et al. | Aug 2004 | A1 |
20040171997 | Wilson et al. | Sep 2004 | A1 |
20040172003 | Wilson et al. | Sep 2004 | A1 |
20040176739 | Stephens et al. | Sep 2004 | A1 |
20040176744 | Lange et al. | Sep 2004 | A1 |
20040176781 | Lindstrom et al. | Sep 2004 | A1 |
20040186444 | Daly et al. | Sep 2004 | A1 |
20040193112 | Glazier et al. | Sep 2004 | A1 |
20040193119 | Canaud et al. | Sep 2004 | A1 |
20040243095 | Nimkar et al. | Dec 2004 | A1 |
20040254534 | Bjorkman et al. | Dec 2004 | A1 |
20040254541 | Wong et al. | Dec 2004 | A1 |
20040260243 | Rickerd | Dec 2004 | A1 |
20040267202 | Potter | Dec 2004 | A1 |
20050010238 | Potter et al. | Jan 2005 | A1 |
20050027257 | Davey | Feb 2005 | A1 |
20050049555 | Moorehead et al. | Mar 2005 | A1 |
20050049628 | Schweikert et al. | Mar 2005 | A1 |
20050090779 | Osypka | Apr 2005 | A1 |
20050113805 | Devellian et al. | May 2005 | A1 |
20050149060 | Thorstenson et al. | Jul 2005 | A1 |
20050245874 | Carrez et al. | Nov 2005 | A1 |
20050257838 | Enerson | Nov 2005 | A1 |
20050267487 | Christensen et al. | Dec 2005 | A1 |
20060030817 | Kraus et al. | Feb 2006 | A1 |
20060052749 | Moyer | Mar 2006 | A1 |
20060149293 | King et al. | Jul 2006 | A1 |
20070123825 | King et al. | May 2007 | A1 |
20070135794 | Raulerson et al. | Jun 2007 | A1 |
20080051717 | Voss et al. | Feb 2008 | A1 |
20080097386 | Osypka | Apr 2008 | A1 |
20080108976 | Johnson et al. | May 2008 | A1 |
20080300538 | Schweikert et al. | Dec 2008 | A1 |
20090105652 | Beal et al. | Apr 2009 | A1 |
20090131873 | Spear et al. | May 2009 | A1 |
20090143739 | Nardeo et al. | Jun 2009 | A1 |
20090177163 | King et al. | Jul 2009 | A1 |
20090218728 | Moyer | Sep 2009 | A1 |
20090234290 | Fisher et al. | Sep 2009 | A1 |
20090299291 | Baid | Dec 2009 | A1 |
20100094226 | Helgeson et al. | Apr 2010 | A1 |
20100101069 | Christensen et al. | Apr 2010 | A1 |
20120143138 | King et al. | Jun 2012 | A1 |
20120184913 | Christensen et al. | Jul 2012 | A1 |
20130226141 | King et al. | Aug 2013 | A1 |
20150119854 | King et al. | Apr 2015 | A1 |
Number | Date | Country |
---|---|---|
103260694 | Aug 2013 | CN |
0370721 | May 1990 | EP |
0442194 | Aug 1991 | EP |
1240916 | Sep 2002 | EP |
2762DELNP2010 | Oct 2011 | IN |
2007511089 | Apr 2007 | JP |
9813083 | Apr 1998 | WO |
0149363 | Jul 2001 | WO |
2004103229 | Dec 2004 | WO |
2005107843 | Nov 2005 | WO |
2007046850 | Apr 2007 | WO |
2007050788 | May 2007 | WO |
2007052278 | May 2007 | WO |
2009052327 | Apr 2009 | WO |
2009097274 | Aug 2009 | WO |
2009114456 | Sep 2009 | WO |
2010102240 | Sep 2010 | WO |
2012083245 | Jun 2012 | WO |
Entry |
---|
US 5,520,663, 05/1996, Patterson et al. (withdrawn) |
U.S. Appl. No. 13/849,261, filed Mar. 22, 2013 Non-Final Office Action dated Aug. 5, 2014. |
U.S. Appl. No. 13/849,261, filed Mar. 22, 2013 Notice of Allowance dated Feb. 27, 2015. |
U.S. Appl. No. 14/585,592, filed Dec. 30, 2014 Notice of Allowance dated Mar. 16, 2015. |
CN 200880121184.X filed Oct. 16, 2008 Decision of Rejection dated Dec. 4, 2012. |
CN 200880121184.X filed Oct. 16, 2008 Office Action dated Aug. 20, 2012. |
CN 200880121184.X filed Oct. 16, 2008 Office Action dated Feb. 16, 2012. |
CN 201180060748.5 filed Jun. 17, 2013 First Office Action dated Oct. 28, 2014. |
EP 08840257.3 Extended European Search Report dated Aug. 12, 2014. |
EP 11848156.3 filed Jul. 16, 2013 extended European search report dated May 2, 2014. |
Hazard Report—ECRI Problem Reporting System, Health Devices, May-Jun. 1996; vol. 25, No. 5-6, pp. 214-215. |
PCT/US2005/015253 filed May 2, 2005 International Preliminary Report on Patentability dated Nov. 1, 2006. |
PCT/US2005/015253 filed May 2, 2005 Search Report dated Aug. 4, 2005. |
PCT/US2005/015253 filed May 2, 2005 Written Opinion dated Aug. 4, 2005. |
PCT/US2008/080227 filed Oct. 16, 2008 International Preliminary Report on Patentability dated Apr. 20, 2010. |
PCT/US2008/080227 filed Oct. 16, 2008 Search Report dated Dec. 23, 2008. |
PCT/US2008/080227 filed Oct. 16, 2008 Written Opinion dated Dec. 23, 2008. |
PCT/US2010/026409 filed Mar. 5, 2010 International Preliminary Report on Patentability dated Apr. 27, 2010. |
PCT/US2010/026409 filed Mar. 5, 2010 Search Report dated Apr. 27, 2010. |
PCT/US2010/026409 filed Mar. 5, 2010 Written Opinion dated Apr. 27, 2010. |
PCT/US2011/065632 filed Dec. 16, 2011 International Preliminary Report on Patentability dated Jun. 18, 2013. |
PCT/US2011/065632 filed Dec. 16, 2011 International Search Report dated Apr. 4, 2012. |
PCT/US2011/065632 filed Dec. 16, 2011 Written Opinion dated Apr. 4, 2012. |
U.S. Appl. No. 11/288,959, filed Nov. 29, 2005 Advisory Action dated Feb. 28, 2014. |
U.S. Appl. No. 11/288,959, filed Nov. 29, 2005 Final Office Action dated Dec. 6, 2013. |
U.S. Appl. No. 11/288,959, filed Nov. 29, 2005 Final Office Action dated Jun. 22, 2009. |
U.S. Appl. No. 11/288,959, filed Nov. 29, 2005 Non-Final Office Action dated Mar. 29, 2013. |
U.S. Appl. No. 11/288,959, filed Nov. 29, 2005 Non-Final Office Action dated Oct. 20, 2008. |
U.S. Appl. No. 11/531,339, filed Sep. 13, 2006 Advisory Action dated Mar. 14, 2014. |
U.S. Appl. No. 11/531,339, filed Sep. 13, 2006 Advisory Action dated Nov. 30, 2012. |
U.S. Appl. No. 11/531,339, filed Sep. 13, 2006 Final Office Action dated Dec. 6, 2013. |
U.S. Appl. No. 11/531,339, filed Sep. 13, 2006 Final Office Action dated Sep. 24, 2012. |
U.S. Appl. No. 11/531,339, filed Sep. 13, 2006 Non-Final Office Action dated Apr. 2, 2013. |
U.S. Appl. No. 11/531,339, filed Sep. 13, 2006 Non-Final Office Action dated Dec. 27, 2011. |
U.S. Appl. No. 11/531,339, filed Sep. 13, 2006 Non-Final Office Action dated Jun. 19, 2014. |
U.S. Appl. No. 11/531,339, filed Sep. 13, 2006 Notice of Allowance dated Sep. 11, 2014. |
U.S. Appl. No. 12/252,975, filed Oct. 16, 2008 Final Office Action dated Jan. 19, 2011. |
U.S. Appl. No. 12/252,975, filed Oct. 16, 2008 Final Office Action dated Nov. 8, 2012. |
U.S. Appl. No. 12/252,975, filed Oct. 16, 2008 Non-Final Office Action dated Apr. 11, 2012. |
U.S. Appl. No. 12/252,975, filed Oct. 16, 2008 Non-Final Office Action dated Sep. 8, 2010. |
U.S. Appl. No. 12/252,975, filed Oct. 16, 2008 Notice of Allowance dated Aug. 20, 2013. |
U.S. Appl. No. 12/252,975, filed Oct. 16, 2008 Notice of Panel Decision dated Dec. 9, 2011. |
U.S. Appl. No. 12/399,749, filed Mar. 6, 2009 Final Office Action dated Oct. 11, 2012. |
U.S. Appl. No. 12/399,749, filed Mar. 6, 2009 Non-Final Office Action dated Mar. 28, 2012. |
U.S. Appl. No. 12/648,533, filed Dec. 29, 2009 Decision on Appeal dated Feb. 2, 2015. |
U.S. Appl. No. 12/648,533, filed Dec. 29, 2009 Examiner's Answer dated Dec. 22, 2011. |
U.S. Appl. No. 12/648,533, filed Dec. 29, 2009 Final Office Action dated Jan. 19, 2011. |
U.S. Appl. No. 12/648,533, filed Dec. 29, 2009 Non-Final Office Action dated Sep. 13, 2010. |
U.S. Appl. No. 12/648,533, filed Dec. 29, 2009 Notice of Panel Decision dated Jun. 16, 2011. |
U.S. Appl. No. 13/329,141, filed Dec. 16, 2011 Advisory Action dated Jul. 11, 2014. |
U.S. Appl. No. 13/329,141, filed Dec. 16, 2011 Final Office Action dated May 8, 2014. |
U.S. Appl. No. 13/329,141, filed Dec. 16, 2011 Non-Final Office Action dated Feb. 14, 2014. |
U.S. Appl. No. 13/434,415, filed Mar. 29, 2012 Non-Final Office Action dated Aug. 15, 2013. |
U.S. Appl. No. 13/434,415, filed Mar. 29, 2012 Notice of Allowance dated Dec. 26, 2013. |
Number | Date | Country | |
---|---|---|---|
20150290424 A1 | Oct 2015 | US |
Number | Date | Country | |
---|---|---|---|
60631397 | Nov 2004 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13849261 | Mar 2013 | US |
Child | 14749323 | US | |
Parent | 12399749 | Mar 2009 | US |
Child | 13849261 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11531339 | Sep 2006 | US |
Child | 12399749 | US | |
Parent | 11288959 | Nov 2005 | US |
Child | 11531339 | US |